Yellowbird Diagnostics Intent to Use Trademark Application
Summary
The USPTO has received an intent-to-use trademark application from Yellowbird Diagnostics for goods and services related to diagnostic reagents, contrast media, and radiopharmaceuticals. The application was filed on November 12, 2025, with an expected use date of March 22, 2026.
What changed
This document is an intent-to-use trademark application filed with the USPTO by Yellowbird Diagnostics. The application, TM99492792, covers a range of products including clinical diagnostic reagents, contrast media for medical imaging, radiopharmaceutical agents for cancer detection, and surgical dyes. The filing date was November 12, 2025, and the applicant has indicated an intent to use the mark by March 22, 2026.
This filing signifies Yellowbird Diagnostics' intention to establish a trademark for its pharmaceutical and diagnostic products. While this is not a regulatory rule or enforcement action, it is a key step in brand protection for companies operating in the pharmaceutical and medical device sectors. Compliance officers should note this filing as it pertains to the commercialization strategy of a company in this space.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
YELLOWBIRD DIAGNOSTICS
Intent to Use TM99492792 Kind: intenttouse Mar 22, 2026
Abstract
clinical diagnostic reagents; contrast media for in vivo imaging; contrast media for use with medical imaging equipment; diagnostic agents for medical use in in vivo scanning; imaging agents for magnetic resonance imaging (MRI); medical imaging contrast media; radio-isotope markers for diagnostic use; radiopharmaceutical agents for use in amyloid pathology detection; radiopharmaceutical imaging and detection agents for diagnosing andmonitoring cancer; radiopharmaceutical preparations for diagnostic purposes; radiopharmaceuticals; surgical dyes; active chemical ingredients for use in the manufacture of pharmaceuticals; carbohydrates used as an ingredient in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the production of medicines
Filing Date
2025-11-12
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.